Related Experiment Video
Updated: Oct 24, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Met35 Oxidation Hinders Aβ25-35 Peptide Aggregation within the Dimyristoylphosphatidylcholine Bilayer
Elias Khayat1, Christopher Lockhart1, Bryan M Delfing1
1School of Systems Biology, George Mason University, Manassas, Virginia 20110, United States.
Abstract:
Using all-atom explicit solvent replica exchange molecular dynamics simulations, we studied the aggregation of oxidized (ox) Aβ25-35 peptides into dimers mediated by the zwitterionic dimyristoylphosphatidylcholine (DMPC) lipid bilayer. By comparing oxAβ25-35 aggregation with that observed for reduced and phosphorylated Aβ25-35 peptides, we elucidated plausible impact of post-translational modifications on cytotoxicity of Aβ peptides involved in Alzheimer's disease. We found that Met35 oxidation reduces helical propensity in oxAβ25-35 peptides bound to the lipid bilayer and enhances backbone fluctuations. These factors destabilize the wild-type head-to-tail dimer interface and lower the aggregation propensity. Met35 oxidation diversifies aggregation pathways by adding monomeric species to the bound conformational ensemble. The oxAβ25-35 dimer becomes partially expelled from the DMPC bilayer and as a result inflicts limited disruption to the bilayer structure compared to wild-type Aβ25-35. Interestingly, the effect of Ser26 phosphorylation is largely opposite, as it preserves the wild-type head-to-tail aggregation interface and strengthens, not weakens, aggregation propensity. The differing effects can be attributed to the sequence locations of these post-translational modifications, since in contrast to Ser26 phosphorylation, Met35 oxidation directly affects the wild-type C-terminal aggregation interface. A comparison with experimental data is provided.
Insights
Oxidation of methionine-35 in amyloid-beta (Aβ) peptides reduces their aggregation and cytotoxicity. In contrast, serine-26 phosphorylation enhances Aβ aggregation, impacting Alzheimer's disease mechanisms.
Area of Science:
- Biochemistry
- Neuroscience
- Computational Biology
Background:
- Alzheimer's disease is linked to amyloid-beta (Aβ) peptide aggregation.
- Post-translational modifications (PTMs) like oxidation and phosphorylation can alter Aβ behavior.
- Understanding PTMs' impact on Aβ aggregation is crucial for disease mechanism insights.
Purpose of the Study:
- To investigate the aggregation of oxidized Aβ25-35 peptides.
- To compare the effects of Met35 oxidation versus Ser26 phosphorylation on Aβ aggregation.
- To elucidate the influence of PTMs on Aβ cytotoxicity and interaction with lipid bilayers.
Main Methods:
- All-atom explicit solvent replica exchange molecular dynamics simulations.
- Studying Aβ25-35 peptide aggregation on a dimyristoylphosphatidylcholine (DMPC) lipid bilayer.
- Comparing aggregation pathways of oxidized, reduced, and phosphorylated Aβ25-35 peptides.
Main Results:
- Met35 oxidation in Aβ25-35 reduces helical propensity and increases backbone fluctuations.
- Oxidation destabilizes the wild-type Aβ dimer interface, lowering aggregation propensity.
- Met35 oxidation leads to partial expulsion of the oxAβ25-35 dimer from the DMPC bilayer.
- Ser26 phosphorylation preserves the wild-type aggregation interface and enhances aggregation propensity.
- PTMs' differing effects correlate with their location within the Aβ sequence.
Conclusions:
- Met35 oxidation modulates Aβ aggregation and reduces its disruptive potential on lipid bilayers.
- Ser26 phosphorylation enhances Aβ aggregation, contrasting with Met35 oxidation effects.
- PTMs significantly influence Aβ aggregation pathways and cytotoxicity, offering insights into Alzheimer's disease.
- Computational simulations provide a valuable approach to study PTMs' effects on Aβ.
More Related Videos
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
06:34A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
Published on: March 27, 2017
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids